COVID-19患者床旁置入隧道式透析导管策略
本研究旨在开发COVID-19大流行中心床旁隧道式透析导管(TDC)置入策略,以提供有效透析通路、节约资源并减少人员暴露。2020年3月19日至6月5日共36例COVID阳性患者透析通路咨询中,24例接受床旁TDC置入,仅1例出现并发症(气胸和心包填塞),院内死亡率为63.9%。结论认为床旁TDC置入可节约资源、避免转运并发症并减少人员暴露,值得进一步考虑。
要点
- 床旁TDC置入在COVID-19患者中可行,仅1例出现并发症。
- 策略可节约资源、避免转运相关并发症并减少人员暴露。
- 该方法可能适用于危重患者,无论其COVID-19状态。
核心结论
- 床旁TDC置入在COVID-19大流行期间可节约资源、避免转运并发症并减少人员暴露,值得进一步考虑并可用于危重患者。
研究设计与样本
- 在ICU开发了超声和X线引导下床旁TDC置入技术,前瞻性收集2020年3月19日至6月5日36例COVID阳性透析通路咨询患者数据,其中24例接受床旁TDC置入。
主要发现
- 24例床旁TDC置入中仅1例出现并发症,为置管过程中气胸和心包填塞。
- 该队列院内死亡率为63.9%。
关键数值与推荐
- 需肾脏替代治疗的COVID-19阳性患者评估行急诊床旁非隧道透析导管(NTDC)或非急诊TDC置入。
- 接受NTDC的患者监测持续肾脏替代治疗需求,3-5天后转为床旁TDC。
临床怎么用
- 对于需要肾脏替代治疗的COVID-19患者,可考虑床旁TDC置入以提供透析通路并减少转运和人员暴露。
- 床旁TDC策略可能同样适用于其他危重患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: COVID-19, the syndrome caused by the novel SARS-CoV2, is associated with high rates of acute kidney injury requiring renal replacement therapy (RRT). It is well known that despite the ease of bedside insertion, the use of nontunneled dialysis catheters (NTDCs) is associated with increased complications compared to tunneled dialysis catheters (TDCs). Our objective was to develop a strategy for TDC placement at the bedside to provide effective dialysis access, conserve resources and decrease personnel exposure at our medical center in an epicenter of the COVID-19 pandemic. METHODS: A technique for bedside TDC insertion with ultrasound and plain radiographs in the intensive care unit was developed. Test or clinically COVID-19-positive patients requiring RRT were evaluated for bedside emergent NTDC or nonemergent TDC placement. Patients who underwent NTDC placement were monitored for ongoing RRT needs and were converted to TDC at the bedside after 3-5 days. We prospectively collected patient data focusing on complications and mortality. RESULTS: Of the 36 consultations for dialysis access in COVID-positive patients from March 19 through June 5, 2020, a total of 24 bedside TDCs were placed. Only one patient developed a complication, which was pneumothorax and cardiac tamponade during line placement. In-hospital mortality in the cohort was 63.9%. CONCLUSIONS: Bedside TDC placement has served to conserve resources, prevent complications with transport to and from the operating room, and decrease personnel exposure during the COVID-19 pandemic. This strategy warrants further consideration and could be used in critically ill patients regardless of COVID status.
引用
- Williams AD, Qaqish M, Elnagar J, et al. Bedside Tunneled Hemodialysis Catheter Placement in Patients with COVID-19. Ann Vasc Surg. 2021. PMID: 33493592. doi:10.1016/j.avsg.2021.01.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。